These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


66 related items for PubMed ID: 16007130

  • 1. A retroviral library genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth suppression in leukemic cells.
    Passioura T, Shen S, Symonds G, Dolnikov A.
    Oncogene; 2005 Nov 10; 24(49):7327-36. PubMed ID: 16007130
    [Abstract] [Full Text] [Related]

  • 2. N-ras-induced growth suppression of myeloid cells is mediated by IRF-1.
    Passioura T, Dolnikov A, Shen S, Symonds G.
    Cancer Res; 2005 Feb 01; 65(3):797-804. PubMed ID: 15705876
    [Abstract] [Full Text] [Related]

  • 3. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S, Passioura T, Symonds G, Dolnikov A.
    Exp Hematol; 2007 Jun 01; 35(6):908-19. PubMed ID: 17533045
    [Abstract] [Full Text] [Related]

  • 4. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.
    Maher J, Colonna F, Baker D, Luzzatto L, Roberts I.
    Exp Hematol; 1994 Jan 01; 22(1):8-12. PubMed ID: 8282064
    [Abstract] [Full Text] [Related]

  • 5. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.
    Lebedeva IV, Su ZZ, Emdad L, Kolomeyer A, Sarkar D, Kitada S, Waxman S, Reed JC, Fisher PB.
    Oncogene; 2007 Feb 01; 26(5):733-44. PubMed ID: 16924242
    [Abstract] [Full Text] [Related]

  • 6. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.
    Krug U, Yasmeen A, Beger C, Bäumer N, Dugas M, Berdel WE, Müller-Tidow C.
    Int J Oncol; 2009 Jan 01; 34(1):129-36. PubMed ID: 19082485
    [Abstract] [Full Text] [Related]

  • 7. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
    Takeda A, Goolsby C, Yaseen NR.
    Cancer Res; 2006 Jul 01; 66(13):6628-37. PubMed ID: 16818636
    [Abstract] [Full Text] [Related]

  • 8. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.
    Gurevich RM, Rosten PM, Schwieger M, Stocking C, Humphries RK.
    Exp Hematol; 2006 Sep 01; 34(9):1192-201. PubMed ID: 16939812
    [Abstract] [Full Text] [Related]

  • 9. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.
    Guo X, Schrader KA, Xu Y, Schrader JW.
    Oncogene; 2005 Mar 31; 24(14):2330-42. PubMed ID: 15735740
    [Abstract] [Full Text] [Related]

  • 10. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
    Fatrai S, Schepers H, Tadema H, Vellenga E, Daenen SM, Schuringa JJ.
    Exp Hematol; 2008 Oct 31; 36(10):1254-65. PubMed ID: 18640764
    [Abstract] [Full Text] [Related]

  • 11. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
    Fleming JB, Shen GL, Holloway SE, Davis M, Brekken RA.
    Mol Cancer Res; 2005 Jul 31; 3(7):413-23. PubMed ID: 16046552
    [Abstract] [Full Text] [Related]

  • 12. An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth.
    Crowder C, Kopantzev E, Williams K, Lengel C, Miki T, Rudikoff S.
    Oncogene; 2003 Feb 06; 22(5):649-59. PubMed ID: 12569357
    [Abstract] [Full Text] [Related]

  • 13. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
    Templin C, Kotlarz D, Rathinam C, Rudolph C, Schätzlein S, Ramireddy K, Rudolph KL, Schlegelberger B, Klein C, Drexler H.
    Exp Hematol; 2008 Feb 06; 36(2):204-15. PubMed ID: 18206728
    [Abstract] [Full Text] [Related]

  • 14. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT.
    Nat Med; 2007 Jan 06; 13(1):78-83. PubMed ID: 17159988
    [Abstract] [Full Text] [Related]

  • 15. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.
    Huang W, Saberwal G, Horvath E, Zhu C, Lindsey S, Eklund EA.
    Mol Cell Biol; 2006 Sep 06; 26(17):6311-32. PubMed ID: 16914719
    [Abstract] [Full Text] [Related]

  • 16. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G.
    Exp Hematol; 2007 Apr 06; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [Abstract] [Full Text] [Related]

  • 17. Study on the bone marrow mesenchymal stem cells induced drug resistance in the U937 cells and its mechanism.
    Lin YM, Zhang GZ, Leng ZX, Lu ZX, Bu LS, Gao S, Yang SJ.
    Chin Med J (Engl); 2006 Jun 05; 119(11):905-10. PubMed ID: 16780769
    [Abstract] [Full Text] [Related]

  • 18. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK, Liang KH, Tzeng CC, Huang GC, Chuang JI, Chang TY, Liu HS.
    Life Sci; 2006 Mar 13; 78(16):1823-9. PubMed ID: 16274703
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L, Huang J, Shirasawa S, Sasazuki T, Augenlicht L.
    Cancer Res; 2007 Sep 15; 67(18):8477-85. PubMed ID: 17875686
    [Abstract] [Full Text] [Related]

  • 20. Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.
    Sun HX, He HW, Zhang SH, Liu TG, Ren KH, He QY, Shao RG.
    Cancer Gene Ther; 2009 Sep 15; 16(9):693-702. PubMed ID: 19247395
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.